Dr. Douglas Boyd
was born in Ottawa, Ontario and is a graduate of Carleton University, and the University of Ottawa for his medical degree.
In September 1999, Dr. Boyd completed the world's first closed-chest, beating-heart coronary artery bypass surgery with the use of the ZEUS Robotic Surgical System, and is recognized throughout the worldwide medical community for his pioneering work in cardiothoracic surgery and the use of robotic surgical systems.
Dr. Boyd is also recognized for performing the first human extracellular matrix xenograft implant for cardiovascular repair in March 2006.
He was the head of the Department of Cardiothoracic Surgery at the Cleveland Clinic in Florida from 2002-2009.
In May of 2009 Dr. Boyd agreed to be the principal investigator for Amadeus® clinical trials manufactured by Titan Medical Inc.(TMD). “I am extremely pleased to join Titan as the principal investigator for upcoming trials of Amadeus®,” said Dr. Boyd. “The company’s robotic surgical platform is indeed evolutionary and overcomes the technical hurdles that are currently faced by surgeons using robotics in surgery.”
In August of 2009 he was named Professor of Surgery, and Director of Robotics and Biosurgery at the University of California, Davis. He is board certified by the Royal College of Physicians and Surgeons of Canada in general and cardiothoracic surgery.
As principal investigator in numerous clinical research trials, Dr. Boyd's research has focused on invasive robotic surgery, image guided minimally invasive cardiothoracic surgery, minimally beating heart surgery, and improving patient safety in cardiac surgery. He has been an invited lecturer at regional, national and international symposia and conferences on his specialty interests. Dr. Boyd has authored or co-authored book chapters in medical textbooks on robotic cardiac bypass surgery and computer-assisted interventions among many other heart-related topics and has published numerous abstracts on his specialty interests.
He has performed robotic assisted CABG since 1997, (over 500 cases) and published or co-published over 50 papers on robotic surgery, developed robotic surgical techniques and mentored dozens of surgeons on the technique of robotic CABG.
Current areas of research include pioneering work in cardiac tissue regeneration with extracellular matrix/stem cells.
Currently Dr. Boyd holds a position of Professor of Surgery, Vice Chair of Surgical Operations & Innovation at the Department of Cardiovascular Sciences, Brody School of Medicine, ECU